Completed NA INTERVENTIONAL 2-arm NCT04973371

Acceptability and Feasibility of Home-based TB Testing

Investigating the Acceptability and Feasibility of Home-based TB Testing of Household Contacts Using a New, Mobile Point-of-care Technology

Sponsor: Foundation for Innovative New Diagnostics, Switzerland

Conditions Households Tuberculosis, Pulmonary

Interventions Home-based point-of-care (POC) TB testing using GeneXpert device + MTB/RIF test

Updated 3 times since 2021 Last updated: Jul 20, 2021 Started: Jul 1, 2018 Primary completion: May 31, 2019 Completion: Jun 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Households and Tuberculosis, Pulmonary, this trial is completed. The trial is conducted by Foundation for Innovative New Diagnostics, Switzerland and has accumulated 3 data snapshots since 2018. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Sep 2021 — Jul 2024 [monthly]

Completed NA

First recorded

Jul 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Foundation for Innovative New Diagnostics, Switzerland
Foundation for Professional Development (Pty) Ltd
Medical Research Council, South Africa
National Institute for Biomedical Imaging and Bioengineering (NIBIB)
National Institutes of Health (NIH)
University of California, Irvine
University of Witwatersrand, South Africa

Data source: Foundation for Professional Development (Pty) Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• East London, South Africa